Should we Repair Ischemic Mitral Regurgitation?

NCT ID: NCT00443365

Last Updated: 2008-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess whether adding mitral valve repair to coronary artery bypass grafting improves outcome in patients with ischemic mitral regurgitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Disease Mitral Valve Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Coronary Artery Bypass Grafting with no Mitral Valve intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

2

Coronary Artery Bypass Grafting + Mitral Annuloplasty

Group Type ACTIVE_COMPARATOR

Mitral valve repair

Intervention Type PROCEDURE

mitral valve annuloplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mitral valve repair

mitral valve annuloplasty

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stable coronary artery disease
* Patient accepted for coronary artery bypass surgery
* Ischemic mitral regurgitation

Exclusion Criteria

* Acute coronary syndrome within 30 days
* Organic valvular heart disease
* Need for other than CABG and mitral valve repair cardiac surgical procedure
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, Poland

OTHER_GOV

Sponsor Role collaborator

Medical University of Silesia

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marek A Deja, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Silesia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

2nd Dept of Cardiac Surgery, Medical University of Silesia

Katowice, , Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marek A Deja, MD PhD

Role: CONTACT

Phone: 48-32-359-8542

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marek A Deja, MD PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6/252/35/3747

Identifier Type: -

Identifier Source: org_study_id